These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15300669)

  • 1. Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report.
    Lezcano E; Gómez-Esteban JC; Zarranz JJ; Alcaraz R; Atarés B; Bilbao G; Garibi J; Lambarri I
    Mov Disord; 2004 Aug; 19(8):973-7. PubMed ID: 15300669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy--parkinsonism. Report of four cases.
    Visser-Vandewalle V; Temel Y; Colle H; van der Linden C
    J Neurosurg; 2003 Apr; 98(4):882-7. PubMed ID: 12691416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson's disease: measuring the on- and off-conditions with FDG-PET.
    Hilker R; Voges J; Thiel A; Ghaemi M; Herholz K; Sturm V; Heiss WD
    J Neural Transm (Vienna); 2002 Oct; 109(10):1257-64. PubMed ID: 12373559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: no effects on, and of, autonomic dysfunction.
    Holmberg B; Corneliusson O; Elam M
    Mov Disord; 2005 Aug; 20(8):976-81. PubMed ID: 15858814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease.
    Stefani A; Lozano AM; Peppe A; Stanzione P; Galati S; Tropepi D; Pierantozzi M; Brusa L; Scarnati E; Mazzone P
    Brain; 2007 Jun; 130(Pt 6):1596-607. PubMed ID: 17251240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report.
    Chou KL; Forman MS; Trojanowski JQ; Hurtig HI; Baltuch GH
    J Neurosurg; 2004 Mar; 100(3):553-6. PubMed ID: 15035294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance.
    Bejjani BP; Dormont D; Pidoux B; Yelnik J; Damier P; Arnulf I; Bonnet AM; Marsault C; Agid Y; Philippon J; Cornu P
    J Neurosurg; 2000 Apr; 92(4):615-25. PubMed ID: 10761650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release.
    Sakellaridis NE
    Neurosurgery; 2005 Mar; 56(3):E629; author reply E629. PubMed ID: 18235260
    [No Abstract]   [Full Text] [Related]  

  • 10. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
    Pinto S; Gentil M; Fraix V; Benabid AL; Pollak P
    J Neurol; 2003 Feb; 250(2):179-87. PubMed ID: 12574948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
    Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
    Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
    Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus stimulation for Parkinson's disease preferentially improves akinesia of proximal arm movements compared to finger movements.
    Wenzelburger R; Kopper F; Zhang BR; Witt K; Hamel W; Weinert D; Kuhtz-Buschbeck J; Gölge M; Illert M; Deuschl G; Krack P
    Mov Disord; 2003 Oct; 18(10):1162-9. PubMed ID: 14534921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapy.
    Schwarz J; Tatsch K; Gasser T; Arnold G; Oertel WH
    Mov Disord; 1997 Nov; 12(6):898-902. PubMed ID: 9399212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
    Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
    J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Sestini S; Scotto di Luzio A; Ammannati F; De Cristofaro MT; Passeri A; Martini S; Pupi A
    J Nucl Med; 2002 Jun; 43(6):725-32. PubMed ID: 12050315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic stimulation in Parkinson disease: with or without anesthesia?
    Maltête D; Navarro S; Welter ML; Roche S; Bonnet AM; Houeto JL; Mesnage V; Pidoux B; Dormont D; Cornu P; Agid Y
    Arch Neurol; 2004 Mar; 61(3):390-2. PubMed ID: 15023817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.